Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IL11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NKTR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ARL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCSK4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTNL9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC15A4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IPO5P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
IP6K3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C7orf73 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HEATR5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD37 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RFFL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GGT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP2B7P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDIPT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GCN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPR132 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXRED2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on